A tetrasaccharide derivative having one or more substituted or unsubstituted amino groups in place of hydroxy groups at unspecified positions.
ChEBI ID: 59412
Member | Definition | Role |
---|---|---|
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc | A branched amino tetrasaccharide consisting of a sialyl residue, linked (2->3) to a galactosyl residue that in turn is linked (1->4) to a glucosaminyl residue, which is also carrying a fucosyl residue at the 3-position. | 3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc.html>alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc |
globotetraose | A linear amino tetrasaccharide consisting of D-glucose at the reducing end having an N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl moiety attached at the 4-position. | 3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp.html>beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (0.21) | 18.7374 |
1990's | 338 (34.74) | 18.2507 |
2000's | 410 (42.14) | 29.6817 |
2010's | 180 (18.50) | 24.3611 |
2020's | 43 (4.42) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 10 (0.99%) | 5.53% |
Reviews | 72 (7.09%) | 6.00% |
Case Studies | 14 (1.38%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 919 (90.54%) | 84.16% |